Nautilus Biotechnology (NAUT) Other Non Operating Income (2021 - 2026)
Nautilus Biotechnology's (NAUT) quarterly Other Non Operating Income came in at -$13000.0 in Q2 2026, up 18.75% year-over-year from -$10947.4 in Q2 2025, and up 18.75% quarter-over-quarter from -$16000.0 in Q2 2025.
Powered by 
Analysis
Nautilus Biotechnology (NAUT) Other Non Operating Income (2021 - 2026) Analysis & Trends
Nautilus Biotechnology has disclosed Other Non Operating Income across 5 years of filings, most recently posting -$13000.0 for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn |
| 10 | Nautilus Biotechnology | 143.03 Mn | 143.03 Mn | 175,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13,000.00 |
| Jun 30, 2025 | -16,000.00 |
| Jun 30, 2023 | -14,000.00 |
| Sep 30, 2022 | -132,000.00 |
| Jun 30, 2022 | 7,000.00 |
| Sep 30, 2021 | -72,000.00 |